ETROFLYT Trademark

Trademark Overview

On Monday, March 11, 2013, a trademark application was filed for ETROFLYT with the United States Patent and Trademark Office. The USPTO has given the ETROFLYT trademark a serial number of 79129607. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 18, 2025. This trademark is owned by Novartis AG. The ETROFLYT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals

General Information

Serial Number79129607
Word MarkETROFLYT
Filing DateMonday, March 11, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 18, 2025
Registration Number4693720
Registration DateTuesday, March 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, December 7, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, May 16, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Saturday, May 18, 2013DEATH OF INTERNATIONAL REGISTRATION
Monday, May 20, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, May 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2013APPLICATION FILING RECEIPT MAILED
Sunday, August 17, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, August 17, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 3, 2014TEAS REQUEST FOR REINSTATEMENT
Monday, September 8, 2014ASSIGNED TO PETITION STAFF
Thursday, September 11, 2014ASSIGNED TO EXAMINER
Thursday, September 11, 2014NON-FINAL ACTION WRITTEN
Friday, September 12, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 12, 2014REFUSAL PROCESSED BY MPU
Friday, September 12, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 10, 2014REFUSAL PROCESSED BY IB
Wednesday, October 22, 2014NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 22, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, October 23, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 27, 2014ASSIGNED TO LIE
Monday, November 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 14, 2014NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 26, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 26, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, December 11, 2014NOTIFICATION PROCESSED BY IB
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, June 3, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 14, 2015FINAL DISPOSITION PROCESSED
Tuesday, July 14, 2015FINAL DISPOSITION NOTICE SENT TO IB
Saturday, August 15, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 30, 2015DEATH OF INTERNATIONAL REGISTRATION
Wednesday, December 30, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, March 24, 2017NOTIFICATION PROCESSED BY IB
Thursday, June 18, 2026DEATH OF INTERNATIONAL REGISTRATION
Thursday, June 18, 2026NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

etroflyt system treatment disorders preparations prevention pharmaceutical anti infectives diseases area